Fundz

Psy Therapeutics, Inc. reported raising $3.97 Million in an initial SEC Form D filing, from an offering of $4.3 Million

PRIVATEOct 02, 2019$4M of $4.3M raised

Amount Raised

$3.97 Million

$3.97 Million sold, per SEC Form D (first sale Oct 2, 2019)

Round Type

Seed

BostonBiotechnologyHealthcare

Quick answer

Psy Therapeutics raised $3.97 Million in a Seed round, dated October 2, 2019. Psy Therapeutics is based in Boston, Massachusetts, United States.

How much did Psy Therapeutics raise?
Psy Therapeutics raised $3.97 Million in a Seed round on October 2, 2019.
What does Psy Therapeutics do?
Psy Therapeutics is discovering and developing unique therapies to improve the lives of people and families affected by neuropsychiatric and neurodegenerative disorders.
Where is Psy Therapeutics based and how big is it?
Psy Therapeutics is based in Boston, Massachusetts, United States.
Who are the decision-makers at Psy Therapeutics?
Fundz holds 1 contact at Psy Therapeutics, including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Psy Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Revolution Medicines raised $100M on November 15, 2019.
  • Vektor Medical raised $3.6M (Seed) on November 15, 2019.
  • ISOThrive raised $4M on November 14, 2019.
  • Lexaria Bioscience raised $180K on November 13, 2019.
  • ColonaryConcepts LLC raised $374K (Seed) on November 7, 2019.
  • Biodexa Pharmaceuticals raised $3M (Seed) on November 7, 2019.

Who to call at Psy Therapeutics, and when

A new round usually means Psy Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Psy Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Psy Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Psy Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Psy Therapeutics

Location

28 ATLANTIC AVE, SUITE 222

Boston, Massachusetts, United States

About

Psy Therapeutics is discovering and developing unique therapies to improve the lives of people and families affected by neuropsychiatric and neurodegenerative disorders. Our robust pipeline of novel small molecules applies innovative platform technologies to targets supported by clinical and preclinical science. This risk-contained approach has led to the discovery of highly brain penetrant and well-tolerated molecules that overcome the limitations of existing treatments. Psy’s mission-focused progress is driven by our team of accomplished biopharma executives, renowned clinicians, and neuroscience experts deeply committed to advancing mental and neurological health.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Psy Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJerry R., Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Psy Therapeutics's next move

See what Strategic adds

Psy Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.